Marijuana Internacional

"Germany’s landmark recreational cannabis law will go into effect on April 1 after clearing the final regulatory hurdle on Friday.

The Bundesrat, the upper house of the German Parliament, failed to reach a majority to convene the Mediation Committee, clearing the last potential delay to approval, ABC News reported.

The law, approved a month ago in the Bundestag by a 407-226 vote, generally
decriminalizes cannabis, allows for home grows and lays the legal framework for so-called “cultivation social clubs – nonprofit organizations where members can acquire marijuana for recreational use.

However, the law
stops short of establishing a regulated retail and distribution system for adult-use products, akin to more than 20 American states."

.
 
Werbung:
"Nearly sixty percent of people undergoing opioid maintenance treatment (OMT) use cannabis to reduce their cravings for other drugs, including heroin, according to survey data published in the journal European Archives of Psychiatry and Clinical Neuroscience.

German investigators assessed cannabis use trends in 118 subjects enrolled in OMT. Fifty-seven percent of respondents acknowledged consuming herbal cannabis,
despite its use being a violation of the program’s rules.

Nearly half (45 percent) of cannabis consumers said that they used it “to reduce cravings for heroin,” and 24 percent acknowledged doing so to reduce cravings for cocaine. Respondents also reported using
cannabis as a substitute for alcohol, benzodiazepines, and other controlled substances."

.
 
"Subjects who engage in the occasional use of cannabis, during their teens, exhibit no significant changes in cognitive functioning in young adulthood, according to longitudinal data published in the journal Psychopharmacology.

Portuguese researchers assessed reward-related brain activity, psychopathology, and cognitive functioning in a cohort of cannabis consumers and controls. Subjects in the study were all cannabis naïve at age 14. Investigators then conducted follow-up investigations when subjects were 19 and 22 years of age.

Researchers did not identify any significant cognitive differences at age 22 between occasional cannabis consumers and abstainers."

.
 
"Patients authorized to use medical cannabis products report decreasing their use of opioids, alcohol, tobacco, and other substances, according to a data analysis published in the journal Cannabis.

Investigators surveyed 2,697 Canadian medical cannabis registrants. The mean age of participants was 54.3 years of age.

Consistent with other surveys, respondents frequently reported substituting cannabis in lieu of other substances."

.
 
Werbung:
Back
Top